Hyperuricemia after liver transplantation in children

Pediatric Transplantation

Volumn 12, Issue 8, 2008, Pages 847-853

  Harambat, Jérôme ^a   Dubourg, Laurence ^a   Ranchin, Bruno ^a   Hadj Aïssa, Aoumeur ^a   Fargue, Sonia ^a   Rivet, Christine ^a   Boillot, Olivier ^a   Lachaux, Alain ^a   Cochat, Pierre ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Child; Glomerular filtration rate; Liver transplantation; Nephrotoxicity; Uric acid

Indexed keywords

ALLOPURINOL; AZATHIOPRINE; CYCLOSPORIN; INULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; URATE; URIC ACID;

ACUTE KIDNEY FAILURE; ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DIET THERAPY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HUMAN; HYPERURICEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RISK ASSESSMENT; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERURICEMIA; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TREATMENT OUTCOME; URIC ACID;

EID: 54849441805     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00950.x     Document Type: Article

References (33)

1. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a non renal organ. N Engl J Med 2003 : 349 : 931 940.
2. Gonwa TA, Mai ML, Melton LB, et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment. Transplantation 2001 : 72 : 1934 1939.
3. Campbell KM, Yazigi M, Ryckman FC, et al. High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation. J Pediatr 2006 : 148 : 475 480.
4. Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study. Arch Int Med 2004 : 164 : 1546 1551.
5. Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? Am J Med 2005 : 118 : 816 826.
6. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004 : 44 : 642 650.
7. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003 : 42 : 247 252.
8. Alper AB, Jr. Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL. Childhood uric acid predicts adult blood pressure: The Bogalusa Heart Study. Hypertension 2005 : 45 : 34 38.
9. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002 : 13 : 2888 2897.
10. Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002 : 282 : F991 F997.
11. Sanchez-Lozada LG, Tapia E, Santamaria J, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 2005 : 67 : 237 247.
12. Mazzali M, Kim YG, Suga S, et al. Hyperuricemia exacerbates chronic cyclosporine nephropathy. Transplantation 2001 : 71 : 900 905.
13. Moreno JM, Cuervas-Mons V, Rubio E, et al. Chronic renal dysfunction after liver transplantation in adult patients: Prevalence, risk factors, and impact on mortality. Transplant Proc 2003 : 35 : 1907 1908.
14. Neal DA, Tom BD, Gimson AE, Gibbs P, Alexander GJ. Hyperuricemia, gout, and renal function after liver transplantation. Transplantation 2001 : 72 : 1689 1691.
15. Taillandier J, Alemanni M, Liote F, Rucay P, Samuel D, Bismuth H. Serum uric acid and liver transplantation. Transplant Proc 1995 : 27 : 2189 2190.
16. Shibolet O, Elinav E, Ilan Y, et al. Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: A long-term follow-up study. Transplantation 2004 : 77 : 1576 1580.
17. Tumgor G, Arikan C, Kilic M, Aydogdu S. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children. Pediatr Transplant 2006 : 10 : 665 668.
18. Wilcox WD. Abnormal serum uric acid levels in children. J Pediatr 1996 : 128 : 731 741.
19. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002 : 39 : S1 S266.
20. Laine J, Krogerus L, Fyhrquist F, Jalanko H, Ronnholm K, Holmberg C. Renal function and histopathologic changes in children after liver transplantation. J Pediatr 1994 : 125 : 863 869.
21. Clive DM. Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 2000 : 11 : 974 979.
22. Noordzij TC, Leunissen KM, Van Hooff JP. Renal handling of urate and the incidence of gouty arthritis during cyclosporine and diuretic use. Transplantation 1991 : 52 : 64 67.
23. Edvardsson VO, Kaiser BA, Polinsky MS, Palmer JA, Quien R, Baluarte HJ. Natural history and etiology of hyperuricemia following pediatric renal transplantation. Pediatr Nephrol 1995 : 9 : 57 60.
24. Lin HY, Rocher LL, Mcquillan MA, Schmaltz S, Palella TD, Fox IH. Cyclosporine-induced hyperuricemia and gout. N Engl J Med 1989 : 321 : 287 292.
25. Zurcher RM, Bock HA, Thiel G. Hyperuricaemia in cyclosporin-treated patients: GFR-related effect. Nephrol Dial Transplant 1996 : 11 : 153 158.
26. Hoyer PF, Lee IJ, Oemar BS, Krohn HP, Offner G, Brodehl J. Renal handling of uric acid under cyclosporin A treatment. Pediatr Nephrol 1988 : 2 : 18 21.
27. Laine J, Holmberg C. Mechanisms of hyperuricemia in cyclosporine-treated renal transplanted children. Nephron 1996 : 74 : 318 323.
28. Marcen R, Gallego N, Orofino L, et al. Impairment of tubular secretion of urate in renal transplant patients on cyclosporine. Nephron 1995 : 70 : 307 313.
29. Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999 : 33 : 225 234.
30. Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003 : 41 : 1287 1293.
31. Abbott KC, Kimmel PL, Dharnidharka V, Oglesby RJ, Agodoa LY, Caillard S. New-onset gout after kidney transplantation: Incidence, risk factors and implications. Transplantation 2005 : 80 : 1383 1391.
32. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006 : 47 : 51 59.
33. Venkat Raman G, Sharman VL, Lee HA. Azathioprine and allopurinol: A potentially dangerous combination. J Int Med 1990 : 228 : 69 71.